tyrphostin 25 has been researched along with Leishmaniasis in 1 studies
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
Excerpt | Relevance | Reference |
---|---|---|
"Genistein treatment of Leishmania-infected cells significantly enhanced the parasite burden." | 1.29 | Leishmania-induced tyrosine phosphorylation in the host macrophage and its implication to infection. ( Assreuy, J; Borges, VM; Cunha e Silva, NL; de Souza, W; Martiny, A; Meyer-Fernandes, JR; Vannier-Santos, MA, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martiny, A | 1 |
Vannier-Santos, MA | 1 |
Borges, VM | 1 |
Meyer-Fernandes, JR | 1 |
Assreuy, J | 1 |
Cunha e Silva, NL | 1 |
de Souza, W | 1 |
1 other study available for tyrphostin 25 and Leishmaniasis
Article | Year |
---|---|
Leishmania-induced tyrosine phosphorylation in the host macrophage and its implication to infection.
Topics: Animals; Benzoquinones; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; | 1996 |